Literature DB >> 21302060

H-2 antigen expression: Loss in vitro, restoration in vivo, and correlation with cell-mediated cytotoxicity in a mouse lymphoma cell line.

O J Finn1, M Lieberman, H S Kaplan.   

Abstract

The susceptibility to cell-mediated cytolysis of cells of the recently developed C57BL/Ka(H-2 ( b )) lymphoma cell line, BL/VL(3), was investigated in allogeneic assays with thymus-dependent lymphocytes (T cells). Compared to EL4, the widely used C57BL/6(H-2 ( b )) lymphoma cell line, BL/VL(3) cells were found to be insensitive to T-cell-mediated lysis as detected by the use of(51)Crrelease methods. When used as immunogens in alloreactive combinations with BALB/c(H-2 ( d )) splenocytes as responder cells, BL/VL(3) cells failed to elicit sensitization. Serological tests showed that this cell line had profoundly reduced levels of H-2(b) antigens on its surface. When BL/VL(3) cells were reinjected into C57BL/Ka and BALB/c mice, full recovery of H-2(b) antigen expression at the cell surface was observed in both syngeneic and allogeneic hosts after only 11 days of in vivo growth. Concomitantly, they acquired the ability to induce cytotoxic responses in allogeneic T cells and became susceptible to their lytic activity. The expression of H-2 antigens on the surface of BL/VL(3) cells is a reversibly modulated function that depends on in vivo growth conditions and is lost in vitro in the absence of immunoselective pressure.

Entities:  

Year:  1978        PMID: 21302060     DOI: 10.1007/BF01843991

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  17 in total

1.  Regulatory variants for the expression of H-2 antigens. II. Level of discrimination of cell-mediated cytolysis.

Authors:  T V Rajan; B R Bloom; S G Nathenson
Journal:  J Natl Cancer Inst       Date:  1976-06       Impact factor: 13.506

2.  Regulatory variants for the expression of H-2 antigens. I. Isolation and characterization.

Authors:  T V Rajan; S G Nathenson; M D Scharff
Journal:  J Natl Cancer Inst       Date:  1976-06       Impact factor: 13.506

3.  HL-A antigens of human lymphoid cells in long-term tissue culture.

Authors:  G N Rogentine; P Gerber
Journal:  Transplantation       Date:  1969-07       Impact factor: 4.939

4.  Persistence of H-2 and some non-H-2 antigens on long-term-cultured mouse cell lines.

Authors:  D Klein; D J Merchant; J Klein; D C Shreffler
Journal:  J Natl Cancer Inst       Date:  1970-05       Impact factor: 13.506

5.  Quantitative studies of antigen expression in cultured murine lymphoma cells. I. Cell-surface antigens in "Asynchronous" cultures.

Authors:  M Cikes; G Klein
Journal:  J Natl Cancer Inst       Date:  1972-12       Impact factor: 13.506

6.  Antigenic expression of a murine lymphoma during growth in vitro.

Authors:  M Cikes
Journal:  Nature       Date:  1970-02-14       Impact factor: 49.962

7.  Specific immune lysis of paramyxovirus-infected cells by H-2-compatible thymus-derived lymphocytes.

Authors:  P C Doherty; R M Zinkernagel
Journal:  Immunology       Date:  1976-07       Impact factor: 7.397

8.  Leukemogenic activity of filtrates from radiation-induced lymphoid tumors of mice.

Authors:  M LIEBERMAN; H S KAPLAN
Journal:  Science       Date:  1959-08-14       Impact factor: 47.728

9.  In vitro induction of cell-mediated immunity to murine leukemia cells. I. Optimization of tissue culture conditions for the generation of cytotoxic lymphocytes.

Authors:  E Kedar; E Unger; M Schwartzbach
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

10.  Evidence for the expression of Ia (H-2-associated) antigens on thymus-derived lymphocytes.

Authors:  J A Frelinger; J E Neiderhuber; C S David; D C Shreffler
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  7 in total

1.  In vivo major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells is regulated by gammadelta T and NK cells during the early steps of tumor growth.

Authors:  Joëlle Riond; Stéphane Rodriguez; Marie-Laure Nicolau; Talal al Saati; Jean Edouard Gairin
Journal:  Cancer Immun       Date:  2009-11-02

2.  Studies on the expression of H-2 antigens in non-metastatic and highly metastatic Friend erythroleukemia cells: correlation with the in vivo behaviour of tumor cells.

Authors:  M Ferrantini; S Pulciani; E Proietti; G Lespinats; A Anastasi; V Ciolli; P Rizza; F Belardelli
Journal:  Clin Exp Metastasis       Date:  1989 Nov-Dec       Impact factor: 5.150

Review 3.  Somatic cell variants of the murine major histocompatibility complex.

Authors:  R A Zeff; P A Kumar; H Mashimo; M Nakagawa; B McCue; F Borriello; K Kesari; J Geliebter; S Hemmi; G Pfaffenbach
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

Review 4.  Role of the major histocompatibility complex in resistance to viral leukemia; its effect on the preleukemic stage of leukemogenesis.

Authors:  P Lonai; E Katz; N Haran-Ghera
Journal:  Springer Semin Immunopathol       Date:  1982

Review 5.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

6.  In vitro elicitation of cytotoxic response against a nonimmunogenic murine tumor by allosensitization.

Authors:  B Leshem; B Gotsman; E Kedar
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 7.  Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants.

Authors:  R S Kerbel; J W Dennis; A E Largarde; P Frost
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.